Is Uber Finally on the Path to Consistent Profitability?
After posting massive losses quarter after quarter for years, Uber…
Sell
40
SBHMY Quote, Financials, Valuation and Earnings
Last price:
$8.79
Seasonality move
:
7.63%
Day range:
$8.79 - $8.79
52-week range:
$6.69 - $10.30
Dividend yield:
2.33%
P/E ratio:
16.53x
P/S ratio:
2.00x
P/B ratio:
1.83x
Volume:
--
Avg. volume:
151
1-year change:
22.08%
Market cap:
$8B
Revenue:
$4B
EPS (TTM):
$0.53
Earnings Data
Next earnings date for SBHMY
Aug 13
2025
Most recent earnings per share
$0.15
Beat by $0.15
(Mar 23/2021)
Consensus Estimate
--
(Mar 23/2021)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
SBHMY Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/23/2021 | Q4 | -- | -- | $0.15 | -- | -- |
| 11/30/2020 | Q3 | -- | -- | $0.09 | -- | -- |
| 08/28/2020 | Q2 | -- | -- | $0.05 | -- | -- |
| 04/21/2020 | Q1 | -- | -- | $0.13 | -- | -- |
| 12/31/2019 | Q4 | -- | -- | $0.08 | -- | -- |
| 11/26/2019 | Q3 | -- | -- | $0.12 | -- | -- |
| 09/27/2019 | Q2 | -- | -- | $0.09 | -- | -- |
| 05/21/2019 | Q1 | -- | -- | $0.13 | -- | -- |
| 12/31/2018 | Q4 | -- | -- | $1.07 | -- | -- |
| 09/30/2018 | Q3 | -- | -- | $0.13 | -- | -- |
| 06/30/2018 | Q2 | -- | -- | $0.10 | -- | -- |
| 03/31/2018 | Q1 | -- | -- | $0.09 | -- | -- |
| 12/31/2017 | Q4 | -- | -- | $0.08 | -- | -- |
| 09/30/2017 | Q3 | -- | -- | $0.12 | -- | -- |
| 06/30/2017 | Q2 | -- | -- | $0.06 | -- | -- |
| 03/31/2017 | Q1 | -- | -- | $0.07 | -- | -- |
| 12/31/2016 | Q4 | -- | -- | $0.04 | -- | -- |
| 09/30/2016 | Q3 | -- | -- | $0.05 | -- | -- |
| 06/30/2016 | Q2 | -- | -- | $0.05 | -- | -- |
| 03/31/2016 | Q1 | -- | -- | $0.05 | -- | -- |
| 12/31/2015 | Q4 | -- | -- | $0.07 | -- | -- |
| 09/30/2015 | Q3 | -- | -- | $0.05 | -- | -- |
| 06/30/2015 | Q2 | -- | -- | $0.05 | -- | -- |
Sino Biopharmaceutical Earnings Questions
-
How Much did Sino Biopharmaceutical Generate in Revenue Last Quarter?
Sino Biopharmaceutical reported -- worth of top line sales in its most recent quarter.
-
Did Sino Biopharmaceutical Beat Earnings Last Quarter?
Sino Biopharmaceutical announced earnings per share of $0.15 which represents a beat of analyst forecast a -- per share.
-
Is Sino Biopharmaceutical Profitable?
Sino Biopharmaceutical reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Sino Biopharmaceutical EPS Next Year?
Sino Biopharmaceutical's earnings are forecast to grow from $0.53 per share to -- per share next year representing an increase of --.
-
When is Sino Biopharmaceutical's Earnings Date?
Sino Biopharmaceutical's next earnings date is August 13, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
How High Will MSTY Go By 2030?
YieldMax’s MSTR Option Income Strategy ETF (MSTY) is a high-yield…
Will NVIDIA Stock Bounce Back?
After the wild market moves during February and March, investors…
Stock Ideas
Sell
48
Is AAPL Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 32x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 31x
Sell
42
Is NVDA Stock a Buy?
Market Cap: $2.5T
P/E Ratio: 36x
Alerts
Sell
25
BULZ alert for Apr 17
MicroSectors Solactive FANG & Innov 3X Levd ETN [BULZ] is down 10.95% over the past day.
Sell
50
IBKR alert for Apr 17
Interactive Brokers Group [IBKR] is down 8.97% over the past day.
Sell
39
FNGA alert for Apr 17
MicroSectors FANG+ Index 3X Leveraged ETN [FNGA] is down 9.37% over the past day.
